Heron Therapeutics enters supply agreement with Patheon and Thermo Fisher
In a recent transaction, Joshua Allen Franks, the Senior Vice President of Operations at e.l.f. Beauty, Inc. (NYSE:ELF), sold shares worth $175,944. According to a filing with the Securities and Exchange Commission, Franks sold 1,496 shares of the company’s common stock at a price of $117.61 per share on June 5, 2025. The company, currently valued at $6.6 billion, has demonstrated impressive performance with a 28% revenue growth and industry-leading gross margins of 71% in the last twelve months.
The transaction was conducted to fulfill tax or other government withholding obligations associated with the vesting of Restricted Stock Units (RSUs). Following this sale, Franks retains direct ownership of 120,471 shares, which includes 47,398 RSUs. According to InvestingPro analysis, the stock appears to be fairly valued, with multiple indicators suggesting high valuation multiples. Subscribers can access 17 additional exclusive ProTips and comprehensive financial metrics for deeper insights into ELF’s valuation and growth prospects.
This sale comes as part of routine financial planning and compliance with tax obligations, as noted in the filing.
In other recent news, e.l.f. Beauty has been the focus of multiple analyst reports and financial updates. The company announced its acquisition of the skincare brand Rhode for $1 billion, a strategic move expected to enhance its growth trajectory. Analysts at Raymond (NSE:RYMD) James have raised their price target for e.l.f. Beauty to $130, citing the acquisition and the company’s innovative strategies. Similarly, Truist Securities increased their price target to $125, reflecting confidence in the company’s future sales and EBITDA figures for fiscal years 2026 and 2027.
Deutsche Bank (ETR:DBKGn) also adjusted its price target to $96, maintaining a Hold rating, while noting the company’s strong fourth-quarter fiscal year 2025 results. TD Cowen expressed optimism by raising their price target to $130 and maintaining a Buy rating, highlighting the potential benefits of the Rhode acquisition. Morgan Stanley (NYSE:MS) increased their price target to $105, acknowledging e.l.f. Beauty’s favorable outcomes regarding tariffs and pricing impacts. Despite the lack of financial guidance for FY26, these developments underscore a positive outlook for e.l.f. Beauty’s market position and growth potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.